Circadian Secretory Pattern of Growth Hormone, Insulin-Like Growth Factor Type I, Cortisol, Adrenocorticotropic Hormone, Thyroid-Stimulating Hormone, and Prolactin during HIV Infection
- 20 September 1997
- journal article
- research article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 13 (14) , 1243-1249
- https://doi.org/10.1089/aid.1997.13.1243
Abstract
The circadian rhythms of plasma growth hormone (GH), insulin-like growth factor type I (IGF-I), cortisol, adrenocorticotropic hormone (ACTH), thyroid-stimulating hormone (TSH), and prolactin (PRL) were evaluated in 13 HIV-seropositive patients (8 males and 5 females; mean age [±SD], 30 ± 5 years), classified as CDC C2. Sixteen clinically healthy subjects (9 males and 7 females; mean age [±SD], 32 ± 8 years) were chosen as control group. Samples were taken every 4 hr from 04:00 to 20:00 and every 2 hr from 20:00 to 04:00. Plasma GH was evaluated by IRMA procedure, plasma IGF-I by RIA (after separation of soluble IGF-I from IGF-I-binding proteins, using acid-ethanol extraction), plasma cortisol by a solid-phase RIA, plasma ACTH by double-antibody RIA, and serum TSH and serum PRL by a solid-phase two-site fluoroimmunometric assay. Rhythmometric data were analyzed by single and population mean cosinor analysis; the comparison of the parameters of the rhythm between patients and controls was carried out by the mesor test and the amplitude-acrophase Hotelling test. Alterations of the circadian pattern of GH, IGF-I, corfisol, ACTH, TSH, and PRL were demonstrated in HIV-seropositive patients. In fact, the circadian profiles of these hormones were clearly flattened and no statistically significant 24-hr rhythm was detectable (with the exception of cortisol). These results are consistent with the hypothesis that alterations of the circadian temporal structure may already be present in HIV-seropositive patients without wasting and infectious complications.Keywords
This publication has 39 references indexed in Scilit:
- Glucocorticoids and interferon-alpha in the acquired immunodeficiency syndromeJournal of Clinical Endocrinology & Metabolism, 1996
- Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndromeJournal of Clinical Endocrinology & Metabolism, 1994
- The Influence of lnterleukin-2 on the Release of Somatostatin and Growth Hormone-Releasing Hormone by Mediobasal HypothalamusNeuroendocrinology, 1993
- Dehydroepiandrosterone as Predictor for Progression to AIDS in Asymptomatic Human Immunodeficiency Virus-Infected MenThe Journal of Infectious Diseases, 1992
- Cytokines and endocrine function: an interaction between the immune and neuroendocrine systemsClinical Endocrinology, 1991
- In vitro and in vivo effect of growth hormone on cytotoxic activityThe Journal of Pediatrics, 1990
- Growth and neuroendocrine dysfunction in children with acquired immunodeficiency syndromeThe Journal of Pediatrics, 1990
- Seasonal modulation of the circadian time structure of circulating T and natural killer lymphocyte subsets from healthy subjects.Journal of Clinical Investigation, 1988
- No real homology of human T-cell leukaemia virus envelope with class I HLANature, 1984
- Circadian variation of lymphocyte subpopulations: a study with monoclonal antibodies.BMJ, 1983